Bookmakers have been offering odds on which stock would be the first to see a share price of $100 or more.
In February this year, it seemed a forgone conclusion that Commonwealth Bank of Australia (ASX: CBA) would win that race, when the shares were priced at around $95.38.
Now, Commonwealth Bank has lost the lead and has not one but three companies that have overtaken it – as you can see from the chart below. Pharmaceutical giant CSL Limited (ASX: CSL) has now held the lead since April 8, but it seemingly has two contenders in the race to $100 in Cochlear Limited (ASX: COH) and newcomer vitamins and supplement producer Blackmores Limited (ASX: BKL).
Blackmores has shot up into contention following an enormous performance so far this year, although to be honest, shares do look a tad expensive currently at $87.40.
With CSL up another 2% to $96.60 today, my money's on the pharmaceutical stock to win the race (not that it really matters in the scheme of things).